Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2021)
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2020)
Development and internal validation of a risk score to detect asymptomatic carotid stenosis
Journal article
Poorthuis M. et al, (2020), European Journal of Vascular and Endovascular Surgery
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article
Zhu P. et al, (2020), J Am Soc Nephrol
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2020), Lancet
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article
HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Blood pressure and kidney disease: chicken or egg (or both)?
Journal article
Staplin N. et al, (2020), Kidney Int, 98, 547 - 549
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
Journal article
Herrington WG. and Staplin N., (2020), Ann Intern Med, 173
In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
Journal article
Herrington WG. and Staplin N., (2020), Ann Intern Med, 173
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.
Journal article
Zhu P. et al, (2020), Int J Obes (Lond)
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Journal article
LANDRAY M. et al, (2020), New England Journal of Medicine
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
Journal article
Horby P. et al, (2020)
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
Journal article
Horby P. et al, (2020)
Accelerometer-measured physical activity and functional behaviours among people on dialysis
Journal article
Nawab K. et al, (2020), Clinical Kidney Journal
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Journal article
Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol
Kidney disease trials for the 21st century: innovations in design and conduct.
Journal article
Herrington WG. et al, (2019), Nat Rev Nephrol
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Journal article
Herrington WG. et al, (2018), Clin Kidney J, 11, 749 - 761